April 15, 2026—Streck released MDx-Chex for RLP, a ready-to-use, full-process molecular quality control designed for respiratory low-plex assay verification. The controls contain intact, inactivated microorganisms suspended in a stabilized patient-like matrix and cover influenza A and B, human rhinovirus, human respiratory syncytial virus, SARS CoV-2, and S. pyogenes. They are instrument agnostic and supplied in single-use vials that can be stored at room temperature. MDx-Chex for RLP is for research use only.
Webinars and Sponsored Roundtables — Register Now
Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY